Newsletter | July 9, 2025

07.09.25 -- U.S. Tariffs And Their Tenuous Impact On Clinical Trials

SPONSOR

Partnerships with Sites, held September 15, 2025, in Philadelphia, is purpose-built for clinical operations professionals looking to elevate collaboration with research sites. Through real-world case studies and strategic discussions, attendees will gain tools to reduce burden, accelerate enrollment, and build stronger sponsor-site relationships. Use code LSL20 for 20% off your registration.

FEATURED ARTICLE

U.S. Tariffs And Their Tenuous Impact On Clinical Trials

RSM US LLP Life Sciences Senior Analyst Amanda Laskey discusses Trump administration tariffs and how they're expected to impact the pharma world, specifically clinical research.

INDUSTRY INSIGHTS

A Patient-Centric Approach To Streamline Pre-Screening Processes

In this presentation from the Patients as Partners conference, Carebox CEO Brian Weiss discusses why it’s time to move past per-study custom pre-screeners.

Building A Strong Safety Culture In The Biopharmaceutical Industry

Explore how fostering a strong safety culture — rooted in accountability, collaboration, and proactive risk management — can drive operational excellence and long-term success in biopharmaceuticals.

Tips For Navigating Tax Season As A 1099-MISC Recipient

Review the tax implications for individuals who received compensation for participating in clinical trials, specifically focusing on the issuance of the 1099-MISC.

Why Engagement Matters In Clinical Trials

Learn about the science behind patient activation, why it matters more than ever in the trial landscape, and how sponsors can harness it to improve recruitment, retention, and overall trial outcomes.

Mastering The Complexities Of Gene Therapy Document Writing

Gain the insight and strategic flexibility needed to confidently navigate the unique scientific, regulatory, and documentation challenges of gene therapy development.

Accelerated Approval As The New "Norm" In Gene Therapy For Rare Diseases

Gene therapy has revolutionized treatment prospects for rare genetic disorders by enabling corrective or replacement strategies at the molecular level.

Optimizing DSP Development: Faster Timelines, Lower Costs

The biopharmaceutical industry faces growing downstream processing challenges in purifying complex biologics efficiently and at scale.